Annual CAPEX
$2.70 M
-$3.27 M-54.76%
31 December 2023
Summary:
Trinity Biotech annual capital expenditures is currently $2.70 million, with the most recent change of -$3.27 million (-54.76%) on 31 December 2023. During the last 3 years, it has fallen by -$7.49 million (-73.48%). TRIB annual CAPEX is now -90.26% below its all-time high of $27.76 million, reached on 31 December 2014.TRIB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$2.70 M
-$469.00 K-14.81%
30 September 2024
Summary:
Trinity Biotech quarterly capital expenditures is currently $2.70 million, with the most recent change of -$469.00 thousand (-14.81%) on 30 September 2024. Over the past year, it has increased by +$2.08 million (+335.16%). TRIB quarterly CAPEX is now -77.99% below its all-time high of $12.26 million, reached on 31 December 2014.TRIB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$8.22 M
+$2.08 M+33.84%
30 September 2024
Summary:
Trinity Biotech TTM capital expenditures is currently $8.22 million, with the most recent change of +$2.08 million (+33.84%) on 30 September 2024. Over the past year, it has increased by +$5.27 million (+178.61%). TRIB TTM CAPEX is now -73.56% below its all-time high of $31.08 million, reached on 30 June 2015.TRIB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.8% | +335.2% | +178.6% |
| 3 y3 years | -73.5% | +37.7% | +34.3% |
| 5 y5 years | -84.5% | -55.4% | -52.7% |
TRIB CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -73.5% | at low | -14.8% | +378.4% | -5.4% | +204.0% |
| 5 y | 5 years | -84.5% | at low | -55.4% | +791.8% | -52.7% | +204.0% |
| alltime | all time | -90.3% | +2604.0% | -78.0% | +166.4% | -73.6% | +213.3% |
Trinity Biotech CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.70 M(-14.8%) | $8.22 M(+33.8%) |
| June 2024 | - | $3.17 M(+116.5%) | $6.14 M(+73.6%) |
| Mar 2024 | - | $1.46 M(+64.2%) | $3.54 M(+30.8%) |
| Dec 2023 | $2.70 M(-54.8%) | $891.00 K(+43.7%) | $2.70 M(-8.3%) |
| Sept 2023 | - | $620.00 K(+9.9%) | $2.95 M(-19.3%) |
| June 2023 | - | $564.00 K(-10.3%) | $3.65 M(-25.3%) |
| Mar 2023 | - | $629.00 K(-44.7%) | $4.89 M(-18.2%) |
| Dec 2022 | $5.98 M(-31.2%) | $1.14 M(-14.1%) | $5.98 M(-18.3%) |
| Sept 2022 | - | $1.32 M(-26.5%) | $7.32 M(-8.0%) |
| June 2022 | - | $1.80 M(+5.0%) | $7.95 M(+5.9%) |
| Mar 2022 | - | $1.72 M(-30.7%) | $7.51 M(-13.6%) |
| Dec 2021 | $8.69 M(-14.8%) | $2.48 M(+26.3%) | $8.69 M(+42.0%) |
| Sept 2021 | - | $1.96 M(+44.0%) | $6.12 M(-10.7%) |
| June 2021 | - | $1.36 M(-53.1%) | $6.85 M(-33.7%) |
| Mar 2021 | - | $2.90 M(-3149.5%) | $10.34 M(+1.4%) |
| Dec 2020 | $10.20 M(-14.0%) | -$95.00 K(-103.5%) | $10.20 M(+3.0%) |
| Sept 2020 | - | $2.69 M(-44.5%) | $9.90 M(-25.3%) |
| June 2020 | - | $4.85 M(+75.8%) | $13.26 M(+15.4%) |
| Mar 2020 | - | $2.76 M(-806.7%) | $11.49 M(-3.0%) |
| Dec 2019 | $11.85 M(-31.8%) | -$390.00 K(-106.4%) | $11.85 M(-31.8%) |
| Sept 2019 | - | $6.05 M(+96.3%) | $17.39 M(-26.3%) |
| June 2019 | - | $3.08 M(-1.1%) | $23.59 M(+43.4%) |
| Mar 2019 | - | $3.11 M(-39.5%) | $16.44 M(-5.4%) |
| Dec 2018 | $17.39 M(+7.5%) | $5.14 M(-58.0%) | $17.39 M(+3.8%) |
| Sept 2018 | - | $12.25 M(-401.6%) | $16.76 M(+103.4%) |
| June 2018 | - | -$4.06 M(-200.0%) | $8.24 M(-46.8%) |
| Mar 2018 | - | $4.06 M(-9.9%) | $15.48 M(-4.3%) |
| Dec 2017 | $16.18 M(-26.0%) | $4.51 M(+21.0%) | $16.18 M(+4.7%) |
| Sept 2017 | - | $3.73 M(+17.0%) | $15.45 M(-10.6%) |
| June 2017 | - | $3.19 M(-33.0%) | $17.28 M(-18.5%) |
| Mar 2017 | - | $4.76 M(+25.8%) | $21.20 M(-3.1%) |
| Dec 2016 | $21.88 M(-21.0%) | $3.78 M(-31.9%) | $21.88 M(-27.5%) |
| Sept 2016 | - | $5.55 M(-21.8%) | $30.17 M(+8.6%) |
| June 2016 | - | $7.11 M(+30.9%) | $27.79 M(-0.4%) |
| Mar 2016 | - | $5.43 M(-55.0%) | $27.90 M(+0.7%) |
| Dec 2015 | $27.70 M(-0.2%) | $12.07 M(+280.1%) | $27.70 M(-0.7%) |
| Sept 2015 | - | $3.18 M(-56.0%) | $27.88 M(-10.3%) |
| June 2015 | - | $7.22 M(+38.2%) | $31.08 M(+11.3%) |
| Mar 2015 | - | $5.22 M(-57.4%) | $27.94 M(+0.7%) |
| Dec 2014 | $27.76 M | $12.26 M(+92.1%) | $27.76 M(+15.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $6.38 M(+56.6%) | $24.11 M(+7.8%) |
| June 2014 | - | $4.08 M(-19.2%) | $22.36 M(-4.0%) |
| Mar 2014 | - | $5.04 M(-41.4%) | $23.31 M(+0.6%) |
| Dec 2013 | $23.18 M(+51.5%) | $8.61 M(+85.5%) | $23.18 M(+9.4%) |
| Sept 2013 | - | $4.64 M(-7.6%) | $21.18 M(+5.5%) |
| June 2013 | - | $5.02 M(+2.2%) | $20.07 M(+12.6%) |
| Mar 2013 | - | $4.91 M(-25.7%) | $17.82 M(+16.5%) |
| Dec 2012 | $15.30 M(+65.6%) | $6.61 M(+87.5%) | $15.30 M(+31.3%) |
| Sept 2012 | - | $3.53 M(+27.3%) | $11.65 M(+14.3%) |
| June 2012 | - | $2.77 M(+16.0%) | $10.19 M(+7.1%) |
| Mar 2012 | - | $2.39 M(-19.5%) | $9.52 M(+3.1%) |
| Dec 2011 | $9.23 M(+2.4%) | $2.97 M(+43.4%) | $9.23 M(-39.6%) |
| Sept 2011 | - | $2.07 M(-1.2%) | $15.29 M(+56.3%) |
| June 2011 | - | $2.09 M(-0.5%) | $9.78 M(-12.1%) |
| Mar 2011 | - | $2.10 M(-76.7%) | $11.12 M(+23.3%) |
| Dec 2010 | $9.02 M(-14.8%) | $9.02 M(-362.5%) | $9.02 M(+96.1%) |
| Sept 2010 | - | -$3.44 M(-200.0%) | $4.60 M(-52.3%) |
| June 2010 | - | $3.44 M(-25.3%) | $9.63 M(-9.0%) |
| Dec 2009 | $10.58 M(-16.6%) | $4.60 M(+187.3%) | $10.58 M(+76.8%) |
| Sept 2009 | - | $1.60 M(-15.2%) | $5.99 M(+36.5%) |
| June 2009 | - | $1.89 M(-24.6%) | $4.39 M(-28.5%) |
| Mar 2009 | - | $2.50 M(-31.3%) | $6.14 M(-1.9%) |
| Dec 2008 | $12.69 M(-21.2%) | - | - |
| June 2008 | - | $3.64 M(+38.7%) | $6.26 M(+138.7%) |
| Mar 2008 | - | $2.62 M | $2.62 M |
| Dec 2007 | $16.11 M(+48.7%) | - | - |
| Dec 2006 | $10.84 M(+168.3%) | - | - |
| Dec 2005 | $4.04 M(-45.6%) | - | - |
| Dec 2004 | $7.42 M(+92.6%) | - | - |
| Dec 2003 | $3.86 M(+53.2%) | - | - |
| Dec 2002 | $2.52 M(+87.4%) | - | - |
| Dec 2001 | $1.34 M(+14.4%) | - | - |
| Dec 2000 | $1.17 M(-18.8%) | - | - |
| Dec 1999 | $1.45 M(-48.4%) | - | - |
| Dec 1998 | $2.80 M(-65.4%) | - | - |
| Dec 1997 | $8.10 M(+224.0%) | - | - |
| Dec 1996 | $2.50 M(+2400.0%) | - | - |
| Dec 1995 | $100.00 K(0.0%) | - | - |
| Dec 1994 | $100.00 K(-87.5%) | - | - |
| Feb 1994 | $800.00 K | - | - |
FAQ
- What is Trinity Biotech annual capital expenditures?
- What is the all time high annual CAPEX for Trinity Biotech?
- What is Trinity Biotech annual CAPEX year-on-year change?
- What is Trinity Biotech quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Trinity Biotech?
- What is Trinity Biotech quarterly CAPEX year-on-year change?
- What is Trinity Biotech TTM capital expenditures?
- What is the all time high TTM CAPEX for Trinity Biotech?
- What is Trinity Biotech TTM CAPEX year-on-year change?
What is Trinity Biotech annual capital expenditures?
The current annual CAPEX of TRIB is $2.70 M
What is the all time high annual CAPEX for Trinity Biotech?
Trinity Biotech all-time high annual capital expenditures is $27.76 M
What is Trinity Biotech annual CAPEX year-on-year change?
Over the past year, TRIB annual capital expenditures has changed by -$3.27 M (-54.76%)
What is Trinity Biotech quarterly capital expenditures?
The current quarterly CAPEX of TRIB is $2.70 M
What is the all time high quarterly CAPEX for Trinity Biotech?
Trinity Biotech all-time high quarterly capital expenditures is $12.26 M
What is Trinity Biotech quarterly CAPEX year-on-year change?
Over the past year, TRIB quarterly capital expenditures has changed by +$2.08 M (+335.16%)
What is Trinity Biotech TTM capital expenditures?
The current TTM CAPEX of TRIB is $8.22 M
What is the all time high TTM CAPEX for Trinity Biotech?
Trinity Biotech all-time high TTM capital expenditures is $31.08 M
What is Trinity Biotech TTM CAPEX year-on-year change?
Over the past year, TRIB TTM capital expenditures has changed by +$5.27 M (+178.61%)